Biomodulators of Anxiety

Preetham Elumalai; Sreeja Lakshmi

doi:doi:10.11648/j.ijcems.20160201.12

| Peer-Reviewed

Biomodulators of Anxiety

Preetham Elumalai, Sreeja Lakshmi

Published in International Journal of Clinical and Experimental Medical Sciences (Volume 2, Issue 1)

Received: 17 December 2015 Accepted: 7 January 2016 Published: 19 February 2016

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Anxiety is a feeling of unease which everyone feels at some points in their lives. Anxiety becomes a disorder when the symptoms become chronic and interfere daily lives, including behavioral patterns and adaptations. Anxiety disorders come in many forms - Generalized Anxiety Disorder, Panic and Post-traumatic Stress disorders, Obsessive Compulsive Disorders, Social Anxiety Disorders and various Phobias. The state of anxiety is modulated by a multifarious and complex series of biomodulators of the categories, neurotransmitters, peptides and hormones comprising serotonin, norepinephrine, Gamma-Aminobutyric acid (GABA), cortisol, Corticotropin Releasing Factor (CRF), Acetylcholine and many more. The article reviews the anxiogenic and/or anxiolytic functions of selected biomodulators in maintaining anxiety related behaviours.

Published in	International Journal of Clinical and Experimental Medical Sciences (Volume 2, Issue 1)
DOI	10.11648/j.ijcems.20160201.12
Page(s)	7-12
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2016. Published by Science Publishing Group

Keywords

Anxiety, GABA, Serotonin, Norepinephrine, HPA Axis

References

[1]	Ninan P T. Dissolving the burden of generalized anxiety disorder. J Clin Psychiatry. 2001; 62.
[2]	Higgins E S and Gorge M S. The neuroscience of clinical psychiatry: The pathophysiology behaviour and mental illness. 1^st edition. 2007.
[3]	Rachman S. Clinical Psychology: Anxiety. 1998.
[4]	Etkin A. Functional neuroanatomy of anxiety: a neural circuit perspective. Curr Top Behav Neurosci. 2010; 251-277.
[5]	Kessler R C, McGonagle K A, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 8-19.
[6]	Gilhotra N and Dhingra D. Neurochemical modulation of anxiety disorders. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; 1-6.
[7]	Ishikawa R, Kobori O and Shimizu E. Development and validation of the Japanese version of the obsessive-compulsive inventory. BMC Res Notes. 2014; 306.
[8]	Fricchione G. Generalized anxiety Disorder. N Engl J Med. 2004; 675-682.
[9]	American Psychiatric Association. Diagnostic and statistical manual of mental disorders (Fifth edition). Washington, D.C.: American Psychiatric Association; 2013.
[10]	Creighton A S, Davison T E and Kissane D W. The prevalence of anxiety among older adults in nursing homes and other aged care facilities: a systematic review. Int J Geriatr Psychiatry. 2015; doi: 10.1002/gps.4378.
[11]	Kang H J, Yoon S and Lyoo I K. Peripheral Biomarker candidates of posttraumatic stress disorder. Exp Neurobiol. 2015; 186-196.
[12]	Schneier F R. Social Anxiety Disorder. N Engl J Med. 2006; 1029-1036.
[13]	Bourne and Edmund J. The anxiety and phobia workbook (5^th ed.) New harbinger Publications. 2011; 50-51.
[14]	Young E A, Abelson J L and Cameron O G. Effect of co-morbid anxiety disorders on the hypothalamic-pituitary-adrenal axis response to a social stressor in major depression. Biol Psychiatry. 2004; 113-120.
[15]	Rose L E, McLean L M. Anxiety disorders during pregnancy and the postpartum period. J Clin Psychiatry. 2006; 1285-1298.
[16]	Gladstone G L, Parker G B, Malhi G S. Do bullied children become anxious and depressed adults?: A cross-sectional investigation of the correlates of bullying and anxious depression. J Nerv Ment Dis. 2006; 201-208.
[17]	Gamez W, Watson D, Doebbeling B N. Abnormality personality and the mood and anxiety disorders: Implications for structural models of anxiety and depression. J Anxiety Disord. 2007; 526-539.
[18]	Karatzias A. Chouliara Z, Power K and Swanson V. Predicting general well-being from self-esteem and affectivity: An extrapolatory study with Scottish adolescents. Qual Life Res. 2006; 1143-1151.
[19]	Steimer T. The biology of fear and anxiety-related behaviours. Dialogues Clin neurosci. 2002; 231-249.
[20]	Deepak M, Alok T S, Paresh W J, Abhijit S V and Anil CV. Neurobilogical modulators of anxiety. International Research Journal of Pharmacy. 2012; 60-64.
[21]	Bannerman DM, Rawlins JN, McHugh SB, et al. Regional dissociations within the hippocampus – memory and anxiety. Neurosci Biobehav Rev. 2004; 273–283.
[22]	Tanaka M, Yoshida M, Emoto H, Ishii H. Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provo- cation of anxiety: basic studies. Eur J Pharmacol. 2000; 397-406.
[23]	Geracioti T D. CSF norepinephrine concentrations in post-traumatic stress disorder. Am J Psychiatry. 2001; 1227-1230.
[24]	Kao C Y, Stalla G, Stalla J, Wotjak CT, Anderzhanova E. Norepinephrine and corticosterone in the medial prefrontal cortex and hippocampus predict PTSD/like symptoms in mice. Eur J Neurosci. 2015; 1139-1148.
[25]	Lin S H, Lee L T and Yang Y K. Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci. 2014; 196-202.
[26]	Marchesi C, Ossola P, Amerio A, Daniel B D, Tonna M, De Panfilis C. Clinical management of perinatal anxiety disorders: A systematic review. J Affect Disord. 2015; 543-550.
[27]	Lanzenberger RR, Mitterhauser M, Spindelegger C, et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry. 2007; 1081-1089.
[28]	Van der Wee N J, van Veen J F, Stevens H, van Vliet I M, van Rijk p P and Westenberg H G. Increased serotonin and dopamine transporter binding in psychotropic medication naive patients with generalized social anxiety disorder shown by ¹²³I-beta-(4-iodophenyl)-tropane SPECT. J Nucl Med. 2008; 757-763.
[29]	Nuss P. Anxiety disorders and GABA neurotransmission: a disturbance of modulation. Neuropsychiatr Dis Treat. 2015; 165-175.
[30]	Mantella RC, Butters MA, Amico JA, et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology. 2008; 773–781.
[31]	Lenze EJ, Mantella RC, Shi P, et al. Elevated cortisol in older adults with Generalized Anxiety Disorder is reduced by treatment: a placebo-controlled evaluation of escitalopram. Am J Geriatr Psychiatry. 2011; 482-490.
[32]	Magin G N, Heinrichs S C and Dunn A J. The role of CRH in behavioral responses to stress. Peptides. 2001; 713-724.
[33]	Victoria B R and Murray B S. Role of Corticotropin Releasing Factor in anxiety disorders: A translational research perspective. Horm Behav. 2006; 550-561.
[34]	Kutlu M G and Gould T J. N. Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochem Pharmacol. 2015; 498-511.
[35]	Tresa M M, Natalie E P, Sharon R G, Stephen E H and Booker T K. 42 Nicotinic acetylcholine receptors on dopaminergic neurones mediate nicotine reward and anxiety relief. J. Neurosci. 2011; 10891-10902.
[36]	Koopmann A, Lemenager T, Wolf N D, et al. The impact of atrial natriuretic peptide on anxiety, stress and craving in patients with alcohol dependence. Alcohol and Alcoholism. 2013; 282-286.
[37]	Rotzinger S and Vaccarino F J. Cholecystokinin receptor subtypes:role in the modulation of anxiety-related and reward-related behaviours in animal models. J Psychiatry Neurosci. 2003; 171-181.
[38]	Moreira F A and Wotlak C T. Cannabinoids and anxiety. Curr Top Behav Neurosci. 2010; 429-450.
[39]	Silk D B, Davis A, Vulevic J, Tzortzis G and Gibson G R. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther. 2009; 508-518.
[40]	Bravo J A, Forsythe P, Chew M V, et al. Ingestion of Lactobacillus strain regulates emotional bahaviour and central GABA receptor expression in an mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011; 16050-16055.
[41]	Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifidobacterium longum NCC 3001 involves vagal pathways for gut-brain communcation. Neurogastroenetrl Motil. 2011; 1132-1139.
[42]	Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan J F and Dinan T G. Effets of the probiotic Bifidobacterium infantis in the maternal seperation model of depression. Neuroscience. 2010; 1179-1188.
[43]	Buydens-Branchey L and Branchey M. n-3 polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol. 2006; 661-665.
[44]	de Sousa DP, Hocayen Pde A, Andrade LN, Andreatini R. A systematic review of the anxiolytic- like effects of essential oils in animal models. Molecules. 2015; 18620-18660.
[45]	Yoga for the Treatment of Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, Depression, and Substance Abuse: A Review of the Clinical Effectiveness and Guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Jun. CADTH Rapid Response Reports. Available from: http://www.ncbi.nlm.nih.gov/books/NBK304569/

Cite This Article

Plain Text BibTeX RIS

APA Style

Preetham Elumalai, Sreeja Lakshmi. (2016). Biomodulators of Anxiety. International Journal of Clinical and Experimental Medical Sciences, 2(1), 7-12. https://doi.org/10.11648/j.ijcems.20160201.12

Copy | Download

ACS Style

Preetham Elumalai; Sreeja Lakshmi. Biomodulators of Anxiety. Int. J. Clin. Exp. Med. Sci. 2016, 2(1), 7-12. doi: 10.11648/j.ijcems.20160201.12

Copy | Download

AMA Style

Preetham Elumalai, Sreeja Lakshmi. Biomodulators of Anxiety. Int J Clin Exp Med Sci. 2016;2(1):7-12. doi: 10.11648/j.ijcems.20160201.12

Copy | Download

@article{10.11648/j.ijcems.20160201.12,
  author = {Preetham Elumalai and Sreeja Lakshmi},
  title = {Biomodulators of Anxiety},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {2},
  number = {1},
  pages = {7-12},
  doi = {10.11648/j.ijcems.20160201.12},
  url = {https://doi.org/10.11648/j.ijcems.20160201.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20160201.12},
  abstract = {Anxiety is a feeling of unease which everyone feels at some points in their lives. Anxiety becomes a disorder when the symptoms become chronic and interfere daily lives, including behavioral patterns and adaptations. Anxiety disorders come in many forms - Generalized Anxiety Disorder, Panic and Post-traumatic Stress disorders, Obsessive Compulsive Disorders, Social Anxiety Disorders and various Phobias. The state of anxiety is modulated by a multifarious and complex series of biomodulators of the categories, neurotransmitters, peptides and hormones comprising serotonin, norepinephrine, Gamma-Aminobutyric acid (GABA), cortisol, Corticotropin Releasing Factor (CRF), Acetylcholine and many more. The article reviews the anxiogenic and/or anxiolytic functions of selected biomodulators in maintaining anxiety related behaviours.},
 year = {2016}
}

Copy | Download

TY  - JOUR
T1  - Biomodulators of Anxiety
AU  - Preetham Elumalai
AU  - Sreeja Lakshmi
Y1  - 2016/02/19
PY  - 2016
N1  - https://doi.org/10.11648/j.ijcems.20160201.12
DO  - 10.11648/j.ijcems.20160201.12
T2  - International Journal of Clinical and Experimental Medical Sciences
JF  - International Journal of Clinical and Experimental Medical Sciences
JO  - International Journal of Clinical and Experimental Medical Sciences
SP  - 7
EP  - 12
PB  - Science Publishing Group
SN  - 2469-8032
UR  - https://doi.org/10.11648/j.ijcems.20160201.12
AB  - Anxiety is a feeling of unease which everyone feels at some points in their lives. Anxiety becomes a disorder when the symptoms become chronic and interfere daily lives, including behavioral patterns and adaptations. Anxiety disorders come in many forms - Generalized Anxiety Disorder, Panic and Post-traumatic Stress disorders, Obsessive Compulsive Disorders, Social Anxiety Disorders and various Phobias. The state of anxiety is modulated by a multifarious and complex series of biomodulators of the categories, neurotransmitters, peptides and hormones comprising serotonin, norepinephrine, Gamma-Aminobutyric acid (GABA), cortisol, Corticotropin Releasing Factor (CRF), Acetylcholine and many more. The article reviews the anxiogenic and/or anxiolytic functions of selected biomodulators in maintaining anxiety related behaviours.
VL  - 2
IS  - 1
ER  -

Copy | Download

Author Information

Preetham Elumalai

School of Aquatic Food Products and Technology, Kerala University of Fisheries and Ocean Studies, Panangad, Kochi, Kerala, India
Sreeja Lakshmi

School of Aquatic Food Products and Technology, Kerala University of Fisheries and Ocean Studies, Panangad, Kochi, Kerala, India

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Preetham Elumalai, Sreeja Lakshmi. (2016). Biomodulators of Anxiety. International Journal of Clinical and Experimental Medical Sciences, 2(1), 7-12. https://doi.org/10.11648/j.ijcems.20160201.12

Copy | Download

ACS Style

Preetham Elumalai; Sreeja Lakshmi. Biomodulators of Anxiety. Int. J. Clin. Exp. Med. Sci. 2016, 2(1), 7-12. doi: 10.11648/j.ijcems.20160201.12

Copy | Download

AMA Style

Preetham Elumalai, Sreeja Lakshmi. Biomodulators of Anxiety. Int J Clin Exp Med Sci. 2016;2(1):7-12. doi: 10.11648/j.ijcems.20160201.12

Copy | Download

@article{10.11648/j.ijcems.20160201.12,
  author = {Preetham Elumalai and Sreeja Lakshmi},
  title = {Biomodulators of Anxiety},
  journal = {International Journal of Clinical and Experimental Medical Sciences},
  volume = {2},
  number = {1},
  pages = {7-12},
  doi = {10.11648/j.ijcems.20160201.12},
  url = {https://doi.org/10.11648/j.ijcems.20160201.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20160201.12},
  abstract = {Anxiety is a feeling of unease which everyone feels at some points in their lives. Anxiety becomes a disorder when the symptoms become chronic and interfere daily lives, including behavioral patterns and adaptations. Anxiety disorders come in many forms - Generalized Anxiety Disorder, Panic and Post-traumatic Stress disorders, Obsessive Compulsive Disorders, Social Anxiety Disorders and various Phobias. The state of anxiety is modulated by a multifarious and complex series of biomodulators of the categories, neurotransmitters, peptides and hormones comprising serotonin, norepinephrine, Gamma-Aminobutyric acid (GABA), cortisol, Corticotropin Releasing Factor (CRF), Acetylcholine and many more. The article reviews the anxiogenic and/or anxiolytic functions of selected biomodulators in maintaining anxiety related behaviours.},
 year = {2016}
}

Copy | Download

TY  - JOUR
T1  - Biomodulators of Anxiety
AU  - Preetham Elumalai
AU  - Sreeja Lakshmi
Y1  - 2016/02/19
PY  - 2016
N1  - https://doi.org/10.11648/j.ijcems.20160201.12
DO  - 10.11648/j.ijcems.20160201.12
T2  - International Journal of Clinical and Experimental Medical Sciences
JF  - International Journal of Clinical and Experimental Medical Sciences
JO  - International Journal of Clinical and Experimental Medical Sciences
SP  - 7
EP  - 12
PB  - Science Publishing Group
SN  - 2469-8032
UR  - https://doi.org/10.11648/j.ijcems.20160201.12
AB  - Anxiety is a feeling of unease which everyone feels at some points in their lives. Anxiety becomes a disorder when the symptoms become chronic and interfere daily lives, including behavioral patterns and adaptations. Anxiety disorders come in many forms - Generalized Anxiety Disorder, Panic and Post-traumatic Stress disorders, Obsessive Compulsive Disorders, Social Anxiety Disorders and various Phobias. The state of anxiety is modulated by a multifarious and complex series of biomodulators of the categories, neurotransmitters, peptides and hormones comprising serotonin, norepinephrine, Gamma-Aminobutyric acid (GABA), cortisol, Corticotropin Releasing Factor (CRF), Acetylcholine and many more. The article reviews the anxiogenic and/or anxiolytic functions of selected biomodulators in maintaining anxiety related behaviours.
VL  - 2
IS  - 1
ER  -

Copy | Download